Oncological and functional results of 50 consecutive radical prostatectomies

##plugins.themes.academic_pro.article.sidebar##

Published Sep 16, 2011
Download
pdf
Vol. 89 No. 9 (2011): Issue Sep 2011

##plugins.themes.academic_pro.article.main##

Ramzi Khiari
Jilani Ghorbel
Mohamed Dridi
Jamel Maarouf
Nawfel Ben Rais
Samir Ghozzi

Abstract

Aim: To evaluate the Oncological and functional results and to clear risk factors of biochemical recurrence in patients with prostate cancer treated by retropubic prostatectomy.
Methods: Retrospective analysis of 50 consecutive retropubic radical prostatectomies performed between January 1999 and january 2008. Biochemical recurrence was defined by PSA > 0.2 ng/ml. Univariate analysis of prognostic factors of biochemical recurrence was performed. The study of the urinary continence and the sexuality is essentially based on a meticulous interrogatory.
Results: The biochemical recurrence-free survival was 68%. Significant risk factors on univariate analysis were: number of positive biopsy, the percentage of positive biopsy, perineural invasion, Gleason score, clinical stage, pathological stage, and tumour volume. On the functional plan, only one patient is totally
incontinent. The return to a normal sexuality appears uncertain, the sexual potency was satisfactory among 5 patients (10% of the patients operated and 55,5% of the patients having had a nervesparing techniques)
Conclusion: Our oncoligical results is acceptable and are quite comparable to literature. This while guaranteeing the satisfactory functional results essentially basing on an acquirement of a continence quasi-perfect.

Keywords:

Prostate cancer; Prostatectomy; continence; sexuality

##plugins.themes.academic_pro.article.details##

References

  1. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long -Term Biochemical disease-free and cancer specific survival following anatomic radical retropubic prostatectomy. Urol. Clin. North Am 2001; 3: 555-65.
  2. Catalona WJ, Smith DS. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: Intermediate term results. J Urol. 1998; 160: 2428-34.
  3. Zincke H, Ward JF, Blute ML, Slezak J. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol. 2003; 170: 1872-76.
  4. Scardino PT, Hull GW, Rabbani F, Abbas F. Cancer control with radical prostatectomy alone in 1000 consecutive patients. J. Urol 2002; 167: 528-34.
  5. Winkler MH, Khan FA, Blake-James B. Case selection for radical prostatectomy in the UK. Eur. Urol 2004; 46: 444-50
  6. Zincke H, Amling CL, Bergstralh EJ. Defining prostate specific antigen progression after prostatectomy: what is the most appropriate cut point? J Urol 2001; 165: 1146-51.
  7. Briganti A, Blute ML, Eastham JH, et al. Pelvic lymph node dissection in prostate cancer. Eur Urol 2009; 55:1251-65.
  8. Burkhard FC, Bader P, Schneider E, Markwalder R, Studer UE. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur Urol 2002; 42: 84-98.
  9. Heidenrich A, Varga Z, Von Knobloch R: Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy:high incidence of lymph node metastasis. J Urol 2002; 167:1681-86.
  10. King CR, Freedland SJ, Terris MK, et al. Optimal timing, cutoff and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH. Urology 2007;69:732-7.
  11. Ficarra V, Novara G, Artibani W, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol 2009; 55:1037-63.
  12. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 2009; 181:956-62.
  13. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual Sanction after anatomic radical prostatectomy. Urology 2000; 55: 58-61.
  14. Kundu SD, Roehl KA, Eggener SE, Antenor JA, Han M, Catalona WJ. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol. 2004 172: 2227-31.
  15. Leandri P, Rossignol G, Gautier JR, Ramon J. Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol 1992; 147: 883-7.
  16. Devonec M, Saussine C, Fourmarier M, et al. Prise en charge de l'incontinence urinaire après prostatectomie totale (CTMH AFU 2006). Prévention de l'incontinence et recommandations du CTMH. Prog Urol 2008;18:89-94.
  17. Walsh PC. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. J Urol 2000; 163: 1802.
  18. Ayyathurai R, Manoharan M, Nieder AM, Kava B, Soloway MS. Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients. BJU Int 2008; 101:833-6.